A deep learning system for predicting time to progression of diabetic retinopathy
-
Published:2024-01-04
Issue:2
Volume:30
Page:584-594
-
ISSN:1078-8956
-
Container-title:Nature Medicine
-
language:en
-
Short-container-title:Nat Med
Author:
Dai Ling, Sheng BinORCID, Chen Tingli, Wu Qiang, Liu RuhanORCID, Cai Chun, Wu Liang, Yang Dawei, Hamzah Haslina, Liu Yuexing, Wang XiangningORCID, Guan ZhouyuORCID, Yu Shujie, Li Tingyao, Tang Ziqi, Ran AnranORCID, Che HaoxuanORCID, Chen HaoORCID, Zheng Yingfeng, Shu Jia, Huang Shan, Wu Chan, Lin Shiqun, Liu Dan, Li Jiajia, Wang Zheyuan, Meng Ziyao, Shen Jie, Hou Xuhong, Deng Chenxin, Ruan Lei, Lu Feng, Chee Miaoli, Quek Ten Cheer, Srinivasan Ramyaa, Raman Rajiv, Sun XiaodongORCID, Wang Ya XingORCID, Wu Jiarui, Jin Hai, Dai Rongping, Shen DinggangORCID, Yang Xiaokang, Guo Minyi, Zhang Cuntai, Cheung Carol Y., Tan Gavin Siew Wei, Tham Yih-ChungORCID, Cheng Ching-YuORCID, Li HuatingORCID, Wong Tien YinORCID, Jia WeipingORCID
Abstract
AbstractDiabetic retinopathy (DR) is the leading cause of preventable blindness worldwide. The risk of DR progression is highly variable among different individuals, making it difficult to predict risk and personalize screening intervals. We developed and validated a deep learning system (DeepDR Plus) to predict time to DR progression within 5 years solely from fundus images. First, we used 717,308 fundus images from 179,327 participants with diabetes to pretrain the system. Subsequently, we trained and validated the system with a multiethnic dataset comprising 118,868 images from 29,868 participants with diabetes. For predicting time to DR progression, the system achieved concordance indexes of 0.754–0.846 and integrated Brier scores of 0.153–0.241 for all times up to 5 years. Furthermore, we validated the system in real-world cohorts of participants with diabetes. The integration with clinical workflow could potentially extend the mean screening interval from 12 months to 31.97 months, and the percentage of participants recommended to be screened at 1–5 years was 30.62%, 20.00%, 19.63%, 11.85% and 17.89%, respectively, while delayed detection of progression to vision-threatening DR was 0.18%. Altogether, the DeepDR Plus system could predict individualized risk and time to DR progression over 5 years, potentially allowing personalized screening intervals.
Publisher
Springer Science and Business Media LLC
Reference63 articles.
1. Cheung, N., Mitchell, P. & Wong, T. Y. Diabetic retinopathy. Lancet 376, 124–136 (2010). 2. Tan, T. -E. & Wong, T. Y. Diabetic retinopathy: looking forward to 2030. Front Endocrinol. 13, 1077669 (2022). 3. Wong, T. Y., Cheung, C. M. G., Larsen, M., Sharma, S. & Simó, R. Diabetic retinopathy. Nat. Rev. Dis. Prim. 2, 16012 (2016). 4. Jenkins, A. J. et al. Biomarkers in diabetic retinopathy. Rev. Diabet. Stud. 12, 159–195 (2015). 5. Stratton, I. M. et al. UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia 44, 156–163 (2001).
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|